CVS
CVS HealthANYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The bull case is that CVS can preserve a higher earnings base if utilization normalizes and PBM rebate/spread pressure becomes manageable, with recent Zepbound coverage headlines potentially improving the commercial access narrative but not yet confirmed here by a primary CVS source [#10-Q-2026-05-06].
Posture
Constructive
Lead driver
Momentum
What changed
News driver: CVS Boosts Outlook for 2026 After Aetna Profits Increase.
What can break
Elevated utilization can still pressure Aetna and related managed-care margins if it persists beyond the quarter [#10-Q-2026-05-06].
Momentum
86
Value
60
Sentiment
48
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $95.00 · Bull $104.00 · Bear $80.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $95.04
Why
Momentum86 · Δ7d -4.4
Value60 · Δ7d +0.2
Sentiment48 · Δ7d +2.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
86
34% active weight
Current posture
7d trendSoftening
Δ7d
-4.4
Δ21d
+10.2
Value
60
32% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+0.8
Sentiment
48
33% active weight
Current posture
7d trendImproving
Δ7d
+2.8
Δ21d
+9.8
Why this grade
Composite grade A. Momentum 86.5 / Value 59.9 / Sentiment 47.9
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$115.62B
Beta
0.49
Shares Out
1.27B
P/E (TTM)
210.7
P/S (TTM)
0.26
P/FCF (TTM)
35.17
Rev YoY
+7.8%
EPS YoY
-4633.1%
Gross Margin
+13.9%
Op Margin
+1.5%
Net Debt
$55.28B
Current Ratio
0.83
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology